Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed May 15, 2019
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Purchase
Common Stock
2019-05-13$1.91/sh+2,400$4,595→ 6,450 total - Purchase
Common Stock
2019-05-14$1.84/sh+2,000$3,679→ 8,450 total - Purchase
Common Stock
2019-05-15$1.45/sh+1,000$1,448→ 9,450 total